Advantis gets FDA clearance for MRI analysis software

By staff writers

April 14, 2023 -- Imaging software developer Advantis Medical Imaging has garnered U.S. Food and Drug Administration (FDA) clearance for its Advantis Platform brain and prostate MRI analysis software.

Advantis had initially received FDA clearance for its Brainance MD brain MRI software in 2021. That software has since been integrated under the Advantis Platform, which now includes a second module for the visualization as well as semiautomated and automated processing of multiparametric prostate MRI exams. Advantis Platform also features a standardized reporting tool, according to the vendor.

The Advantis Platform is available as a software-as-a-service, Advantis said.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking